Sandra Thierstein

799 total citations
12 papers, 223 citations indexed

About

Sandra Thierstein is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Sandra Thierstein has authored 12 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Surgery. Recurrent topics in Sandra Thierstein's work include Lung Cancer Diagnosis and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Sandra Thierstein is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Sandra Thierstein collaborates with scholars based in Switzerland, Canada and Netherlands. Sandra Thierstein's co-authors include Miklos Pless, Solange Peters, Markus Furrer, Roger Stupp, Rolf A. Stahel, Daniel Betticher, Walter Weder, Ralph A. Schmid, Arnaud Roth and Matthias Gückenberger and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Scientific Reports.

In The Last Decade

Sandra Thierstein

12 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Thierstein Switzerland 8 155 96 53 43 29 12 223
Zhichao Zuo China 8 120 0.8× 126 1.3× 65 1.2× 57 1.3× 24 0.8× 42 263
G.A. Jiménez Londoño Spain 9 102 0.7× 156 1.6× 28 0.5× 27 0.6× 17 0.6× 39 248
E.I. Eboulet Switzerland 9 125 0.8× 59 0.6× 12 0.2× 76 1.8× 21 0.7× 15 171
Zongrui Ma China 8 79 0.5× 192 2.0× 32 0.6× 25 0.6× 58 2.0× 13 236
Anne-Maree Haynes Australia 6 221 1.4× 115 1.2× 17 0.3× 23 0.5× 17 0.6× 6 265
Zhen‐Bin Qiu China 9 114 0.7× 88 0.9× 22 0.4× 71 1.7× 19 0.7× 25 206
Erik V. Soloff United States 8 69 0.4× 100 1.0× 56 1.1× 154 3.6× 30 1.0× 21 204
Jacques-Antoine Maisonobe France 5 105 0.7× 350 3.6× 21 0.4× 52 1.2× 92 3.2× 10 369
Yikai Xu China 4 83 0.5× 119 1.2× 28 0.5× 53 1.2× 44 1.5× 6 217
Viktoria Schütz Germany 10 218 1.4× 90 0.9× 41 0.8× 18 0.4× 23 0.8× 24 266

Countries citing papers authored by Sandra Thierstein

Since Specialization
Citations

This map shows the geographic impact of Sandra Thierstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Thierstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Thierstein more than expected).

Fields of papers citing papers by Sandra Thierstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Thierstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Thierstein. The network helps show where Sandra Thierstein may publish in the future.

Co-authorship network of co-authors of Sandra Thierstein

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Thierstein. A scholar is included among the top collaborators of Sandra Thierstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Thierstein. Sandra Thierstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vuong, Diem, Marta Bogowicz, Martin Hüllner, et al.. (2021). Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging. EJNMMI Research. 11(1). 79–79. 12 indexed citations
2.
Vuong, Diem, Marta Bogowicz, Leonard Wee, et al.. (2021). Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC. Scientific Reports. 11(1). 20890–20890. 5 indexed citations
3.
Vuong, Diem, Marta Bogowicz, Matea Pavic, et al.. (2021). Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types. British Journal of Radiology. 94(1120). 20200947–20200947. 23 indexed citations
4.
Vuong, Diem, Stephanie Tanadini‐Lang, Robert J. Marks, et al.. (2020). Radiomics Feature Activation Maps as a New Tool for Signature Interpretability. Frontiers in Oncology. 10. 578895–578895. 19 indexed citations
5.
Vuong, Diem, Marta Bogowicz, Robert Foerster, et al.. (2020). Comparison of robust to standardized CT radiomics models to predict overall survival for non‐small cell lung cancer patients. Medical Physics. 47(9). 4045–4053. 16 indexed citations
6.
Vuong, Diem, Marta Bogowicz, Jan Unkelbach, et al.. (2019). EP-1910 CT image standardization is superior to larger but heterogeneous datasets for robust radiomic models. Radiotherapy and Oncology. 133. S1037–S1038. 1 indexed citations
7.
Steffen, Thomas, Daniel Dietrich, Annelies Schnider, et al.. (2017). Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer. Annals of Surgery. 269(1). 83–87. 32 indexed citations
8.
9.
10.
11.
Stupp, Roger, Michael Mayer, Roger Kann, et al.. (2009). Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. The Lancet Oncology. 10(8). 785–793. 87 indexed citations
12.
Pless, Miklos, Roger Stupp, Michael Mayer, et al.. (2007). Preoperative chemoradiotherapy in non-small cell lung cancer (NSCLC) patients with operable stage IIIB disease. A phase II trial of the Swiss Group for Clinical Cancer Research (SAKK). Journal of Clinical Oncology. 25(18_suppl). 18021–18021. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhichao Zuo Breakdown of academic impact, for papers by G.A. Jiménez Londoño Breakdown of academic impact, for papers by E.I. Eboulet Breakdown of academic impact, for papers by Zongrui Ma Breakdown of academic impact, for papers by Anne-Maree Haynes Breakdown of academic impact, for papers by Zhen‐Bin Qiu Breakdown of academic impact, for papers by Erik V. Soloff Breakdown of academic impact, for papers by Jacques-Antoine Maisonobe Breakdown of academic impact, for papers by Yikai Xu Breakdown of academic impact, for papers by Viktoria Schütz
Rankless by CCL
2026